retatrutide

Eli Lilly said Wednesday it is suing six companies selling versions of its experimental weight-loss drug retatrutide, calling it the beginning of a concerted effort to crack down on a vast illicit market. That market has boomed even though retatrutide is still being studied in clinical trials and hasn’t been approved by the Food and…